Highly Prescribed Drug Gets FDA Green Light Despite 4-Fold Higher Risk of Death

Contact Your Elected Officials
The Epoch Times Header

The FDA approved a drug already used in nursing homes, but experts are concerned about its potentially lethal effects.

A questionable green light from the U.S. Food and Drug Administration (FDA). An unproven drug frequently used in nursing homes. Medical experts left confused and concerned.

This is the story surrounding brexpiprazole, branded as Rexulti: the first antipsychotic approved to treat agitation in Alzheimer’s patients despite alarmingly high death rates and poor results in clinical trials.

Patients prescribed brexpiprazole faced a fourfold increased risk of dying compared to people who didn’t take the drug, according to an investigation published in the British Medical Journal (BMJ).

For medical professionals, the FDA’s move raises troubling questions about efficacy, safety, and regulatory diligence.

Watchdog Group Flags Dangers as FDA OKs Alzheimer’s Drug

In an open letter (pdf) from May 3, Nina Zeldes, who has a doctorate in medical anthropology and is a drug safety advocate and researcher for Public Citizen, a consumer advocacy organization, urged the FDA to reject the drug manufacturer’s bid. She argued that the drug has no meaningful benefits and increases patients’ risk of harm.

Approving ineffective drugs erodes public trust and gives false hope to families of Alzheimer’s patients, Ms. Zeldes wrote. Patients need to trust that FDA-approved drugs are safe and effective, she added.

Ms. Zeldes also noted that up to 21 percent of nursing home residents already receive risky antipsychotics, citing a New York Times investigation. According to Ms. Zeldes, approving brexpiprazole could increase the use of these potentially deadly drugs.

However, one week later, on May 11, the FDA approved brexpiprazole to treat agitation in Alzheimer’s patients, citing clinical trials showing “statistically significant and clinically meaningful improvements.”

What Did the Clinical Trials Really Show?

The efficacy of drugs for treating Alzheimer’s dementia is based on a scale called the Cohen-Mansfield Agitation Inventory (CMAI) (pdf) that measures 29 behaviors. Caregivers assign a score of 1 to 7 for each statement for a total score of 29 to 203. Some behaviors listed on the scale include how often a patient:

  • Hits, kicks, and screams.
  • Is restless or paces aimlessly.
  • Screams or curses.
  • Repeatedly asks the same question.
  • Complains or is excessively negative.

To determine effectiveness, a patient’s score must change by a value of 17 after 12 weeks of an intervention to be of clinical value. However, the brexpiprazole trials showed only a 5.3-point maximum reduction in CMAI scores, according to the open letter—far below the efficacy threshold.

Brexpiprazole also increased mortality risk. Over 16 weeks, death rates were four times higher among those prescribed the drug versus placebo. 

Furthermore, common adverse side effects include urinary tract infection, sleepiness, insomnia, and higher incidences of cardiovascular events, Ms. Zeldes added.

By Mary Gillis

Read Full Article on TheEpochTimes.com

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

The Paradoxical Patriot: The political odyssey of Frank S. Meyer

In his book, Daniel J. Flynn examines the ideological evolution of one of conservatism’s most paradoxical and overlooked architects, Frank S. Meyer. 

This Is America: Target™ Reparations

“This Is America” explores the cultural undercurrents pulling Western...

Blind Man’s Shutdown

Congress is playing the equivalent of Bind Man's Bluff. With the shout “tag your it” they seek to blame the other party for the government shutdown.

A Reluctant Acknowledgment: What Conservatives Can Admire in Everyday Progressives

Admirable ideological qualities seen in liberals and left-wing individuals are those of the everyday believer not their political leadership.

Ensuring Domestic Tranquility

The Supremacy Clause in Article VI of the U.S. Constitution establishes it as the highest law of the land, taking precedence over conflicting state laws.

Hegseth Says Military Has Every Authorization Needed for Strikes on Drug Boats

Defense Sec. Pete Hegseth said the U.S. military is authorized to strike drug-running boats off Venezuela’s coast in the Caribbean Sea.

White House Official Says Layoffs Will Start Soon If Shutdown Talks Go Nowhere

Kevin Hassett said layoffs to federal workforce could occur quickly if negotiations with Democrats to reopen the government don’t lead to progress.

20 Teachers in California Facing Disciplinary Action for Posts on Charlie Kirk

California school districts move to discipline teachers for derogatory social media posts about the assassination of Charlie Kirk.

Trump Coal Boost Gains Momentum as Bids, Land Opened Up

Trump administration accelerates coal expansion with new leases, mine permits, and 13.1 million acres of federal land opened for coal mining.

Department of Energy Cancels $7.5 Billion in Project Funding

The Dept of Energy (DOE) said on Oct. 2 that it had terminated 321 federal grants funding 223 projects, amounting to about $7.56 billion in cuts.

White House Withdraws EJ Antoni’s Nomination to Lead Bureau of Labor Statistics

The White House has withdrawn economist EJ Antoni’s nomination to lead the Bureau of Labor Statistics, the White House confirmed on Sept. 30.

US to Impose 100 Percent Tariffs on Foreign-Made Movies, Trump Says

President Donald Trump announced on Sept. 29 that he will impose a 100 percent tariff on all movies produced outside the United States.

Trump to Host Netanyahu at White House to Discuss Gaza Peace Plan

President Trump will host Israeli Prime Minister Netanyahu at the White House on Sept. 29 to discuss a ceasefire and broader peace plan for Gaza.
spot_img

Related Articles

Popular Categories

MAGA Business Central